TY - JOUR
T1 - Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR<45 mL/min/1.73 m2): a summary document from the European Renal Best Practice Group
AU - Farrington, Ken
AU - Covic, Adrian
AU - Nistor, Ionut
AU - Aucella, Filippo
AU - Clyne, Naomi
AU - de Vos, Leen
AU - Findlay, Andrew
AU - Fouque, Denis
AU - Grodzicki, Tomasz
AU - Iyasere, Osasuyi
AU - Jager, Kitty J.
AU - Joosten, Hanneke
AU - Macias, Juan Florencio
AU - Mooney, Andrew
AU - Nagler, Evi
AU - Nitsch, Dorothea
AU - Taal, Maarten
AU - Tattersall, James
AU - Stryckers, Marijke
AU - van Asselt, Dieneke
AU - van den Noortgate, Nele
AU - van der Veer, Sabine
AU - van Biesen, Wim
PY - 2017
Y1 - 2017
N2 - The population of patients with moderate and severe CKD is growing. Frail and older patients comprise an increasing proportion. Many studies still exclude this group, so the evidence base is limited. In 2013 the advisory board of ERBP initiated, in collaboration with European Union of Geriatric Medicine Societies (EUGMS), the development of a guideline on the management of older patients with CKD stage 3b or higher (eGFR >45 mL/min/1.73 m2). The full guideline has recently been published and is freely available online and on the website of ERBP (www.european-renal-best-practice.org). This paper summarises main recommendations of the guideline and their underlying rationales
AB - The population of patients with moderate and severe CKD is growing. Frail and older patients comprise an increasing proportion. Many studies still exclude this group, so the evidence base is limited. In 2013 the advisory board of ERBP initiated, in collaboration with European Union of Geriatric Medicine Societies (EUGMS), the development of a guideline on the management of older patients with CKD stage 3b or higher (eGFR >45 mL/min/1.73 m2). The full guideline has recently been published and is freely available online and on the website of ERBP (www.european-renal-best-practice.org). This paper summarises main recommendations of the guideline and their underlying rationales
U2 - https://doi.org/10.1093/ndt/gfw411
DO - https://doi.org/10.1093/ndt/gfw411
M3 - Article
C2 - 28391313
SN - 0931-0509
VL - 32
SP - 9
EP - 16
JO - Nephrology, dialysis, transplantation
JF - Nephrology, dialysis, transplantation
IS - 1
ER -